Literature DB >> 8607419

Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis.

A M Atz1, I Adatia, R A Jonas, D L Wessel.   

Abstract

We demonstrated selective pulmonary vasodilation in patients with congenital mitral stenosis with inhaled NO, and used NO as prolonged therapy to stabilize the postintervention course of these children. The pulmonary vasoreactivity was greater than that previously reported in adults and may be due to particular sensitivity of pulmonary veins to inhaled NO when pulmonary venous hypertension has been present since birth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607419     DOI: 10.1016/s0002-9149(97)89404-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Perioperative management of pulmonary hypertension in children with critical heart disease.

Authors:  Ronald A Bronicki
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

Review 2.  Pulmonary hypertension caused by pulmonary venous hypertension.

Authors:  Thomas J Kulik
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

3.  Inhaled nitric oxide applications in paediatric practice.

Authors:  A Bernasconi; M Beghetti
Journal:  Images Paediatr Cardiol       Date:  2002-01

4.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension in children.

Authors:  Maha Al Dabbagh; Hanna Banjar; Nasser Galal; Amjad Kouatli; Hammam Kandil; May Chehab
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.